Arkos Global Advisors - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Arkos Global Advisors ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$1,631
-10.6%
60,6120.0%0.33%
-5.7%
Q2 2023$1,825
-6.5%
60,612
+0.5%
0.35%
-10.7%
Q1 2023$1,952
+263.5%
60,338
+222.0%
0.39%
+187.6%
Q4 2022$537
-99.8%
18,738
+27.6%
0.14%
+29.2%
Q3 2022$354,000
-11.9%
14,6880.0%0.11%
-7.0%
Q2 2022$402,000
-28.6%
14,6880.0%0.11%
-22.4%
Q1 2022$563,000
+5.2%
14,688
-12.1%
0.15%
-9.8%
Q4 2021$535,000
+29.5%
16,716
+19.3%
0.16%
+18.1%
Q3 2021$413,000
-2.6%
14,016
+12.4%
0.14%
-6.1%
Q2 2021$424,000
+25.8%
12,471
+20.4%
0.15%
+14.0%
Q1 2021$337,000
-14.0%
10,358
-4.9%
0.13%
-19.4%
Q4 2020$392,000
-45.7%
10,889
-41.0%
0.16%
-51.7%
Q3 2020$722,000
-81.0%
18,449
-82.2%
0.33%
-83.3%
Q2 2020$3,809,000
+34.4%
103,836
-15.6%
1.99%
+6.9%
Q1 2020$2,835,000
+7.8%
123,056
+37.1%
1.86%
+8.3%
Q4 2019$2,629,000
+2.9%
89,774
-6.1%
1.72%
-5.3%
Q3 2019$2,555,000
+2.9%
95,640
-1.6%
1.81%
-0.8%
Q2 2019$2,484,000
+16.5%
97,192
+2.2%
1.83%
+14.2%
Q1 2019$2,132,000
+0.9%
95,072
-5.2%
1.60%
-7.3%
Q4 2018$2,114,000100,2501.73%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders